Key result
The proposed analogue front end for capacitive biopotential measurements significantly increased the signal-to-noise ratio in cEMG (p < 0.01) and improved cECG stability.
Why the study?
Does a novel analogue front end improve signal quality and stability in capacitive biopotential measurements in human subjects?
Does a novel analogue front end improve signal quality and stability in capacitive biopotential measurements in human subjects?
p-value: p=< 0.01
A novel analogue front end provides a feasible balance between sensitivity and stability for capacitive biopotential measurements, offering a potential replacement for conventional voltage followers.
May enable improved non-contact monitoring; leaves open clinical validation in larger cohorts.
This paper proposes a novel analogue front end (AFE) that has three features: voltage-dependent input impedance, bandpass amplification, and stray capacitance reduction. With a view to applying the AFE to capacitive biopotential measurements (CBMs), the three features were investigated separately in a schematic and mathematical manner. Capacitive electrocardiogram (cECG) or capacitive electromyogram (cEMG) measurements using the AFE were performed in low-humidity conditions (below 35% relative humidity) for a total of seven human subjects. Performance evaluation of the AFE revealed the following: (1) the proposed AFE in cECG measurement with 1.70-mm thick clothing reduced the baseline recovery time and root mean square voltage of respiratory interference in subjects with healthy-weight body mass index (BMI), and increased R-wave amplitude for overweight-BMI subjects; and (2) the proposed AFE in cEMG measurement of biceps brachii muscle yielded stable electromyographic waveforms without the marked DC component for all subjects and a significant (p < 0.01) increase in the signal-to-noise ratio. These results indicate that the proposed AFE can provide a feasible balance between sensitivity and stability in CBMs, and it could be a versatile replacement for the conventional voltage follower used in CBMs.
No takes yet. Share an insight, caveat, or question.
Nakamura et al. (2020) studied Capacitive biopotential measurements (n=7). Novel analogue front end (AFE) with voltage-dependent input impedance and bandpass amplification vs. Conventional voltage follower was evaluated on Signal-to-noise ratio and baseline recovery time / respiratory interference (p=< 0.01). The proposed analogue front end for capacitive biopotential measurements significantly increased the signal-to-noise ratio in cEMG (p < 0.01) and improved cECG stability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: